Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
Q1 2026 earnings • released • EPS beat +7.33% • Revenue beat +3.31%
See results
EW:NYSE
Edwards Lifesciences Corp
$79.72
-2.22%
(-1.81) 1D
$83.49
+4.73% (+3.77)
After hours
Closed: Apr 23, 4:00:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EW...
Open
$81.53
High
$82.00
Low
$79.19
Mkt. cap
45.96B
Avg. vol.
4.76M
Volume
0.00
P/E ratio
44.05
52-wk high
$87.89
52-wk low
$69.84
EPS
$1.81
Beta
0.95
Shares outstanding
576.54M
No. of employees
16K
News stories
From sources across the web
Orange County Business Journal
Orange County Business Journal
·
6 hours ago
Edwards Q1 Results Exceed Expectations
Investor's Business Daily
Investor's Business Daily
·
6 hours ago
Investors Show Some Love To This Heart-Healthy Stock
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility completed in 2021 in Limerick, Ireland. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Last report
Apr 23, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0.78/ (0.73 est.)USD
+7.33%beat
Revenue / Estimate
1.65B/ (1.60B est.)USD
+3.31%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.41B
1.53B
1.55B
1.57B
Cost of goods sold
301.60M
344.40M
345.20M
343.00M
Cost of revenue
301.60M
344.40M
345.20M
343.00M
Research and development expenses
254.60M
276.20M
280.70M
267.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
465.70M
502.00M
514.60M
601.20M
Operating expense
701.20M
756.90M
782.80M
854.60M
Total operating expenses
1.00B
1.10B
1.13B
1.20B
Operating income
409.90M
430.90M
425.10M
372.00M
Other non operating income
900.00K
-49.90M
1.10M
2.30M
EBT including unusual items
433.90M
400.20M
348.40M
90.40M
EBT excluding unusual items
432.00M
400.90M
444.50M
464.00M
Income tax expense
70.30M
64.30M
56.10M
26.20M
Effective tax rate
16.20%
16.07%
16.10%
28.98%
Other operating expenses
-19.10M
-21.30M
-12.50M
-14.30M
Net income
358.00M
333.20M
291.10M
91.20M
Net profit margin
25.34%
21.75%
18.74%
5.81%
Earnings per share
0.64
0.67
0.67
0.58
Interest and investment income
19.50M
18.40M
16.70M
114.20M
Interest expense
-
-
-
-20.40M
Net interest expenses
19.50M
18.40M
16.70M
93.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
446.50M
469.00M
464.30M
414.70M
Gain or loss from assets sale
-
-
-
-33.90M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more